LENZ
LENZ Therapeutics
LENZ
LENZ
94 hedge funds and large institutions have $573M invested in LENZ Therapeutics in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 8 closing their positions.
Holders
94
Holders Change
+16
Holders Change %
+20.51%
% of All Funds
1.25%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
24
Increased
33
Reduced
20
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PBA
1
Paradigm Biocapital Advisors
New York
|
$22.2M |
| 2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$23.8M |
| 3 |
3
BlackRock
New York
|
$33.4M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$14.3M |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$2.48M |
